Molecular pathways driving omeprazole nephrotoxicity
Omeprazole, a proton pump inhibitor used to treat peptic ulcer and gastroesophageal reflux disease, has been associated to chronic kidney disease and acute interstitial nephritis. However, whether omeprazole is toxic to renal cells is unknown. Omeprazole has a lethal effect over some cancer cells, a...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231719316076 |
id |
doaj-e594dab90e2845f7b432784f16cd8f38 |
---|---|
record_format |
Article |
spelling |
doaj-e594dab90e2845f7b432784f16cd8f382020-11-25T03:23:36ZengElsevierRedox Biology2213-23172020-05-0132Molecular pathways driving omeprazole nephrotoxicityMiguel Fontecha-Barriuso0Diego Martín-Sanchez1Julio M. Martinez-Moreno2Daniela Cardenas-Villacres3Susana Carrasco4Maria D. Sanchez-Niño5Marta Ruiz-Ortega6Alberto Ortiz7Ana B. Sanz8Research Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, Spain; REDINREN, Madrid, SpainResearch Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, Spain; REDINREN, Madrid, SpainResearch Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, SpainResearch Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, SpainResearch Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, SpainResearch Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, Spain; REDINREN, Madrid, SpainResearch Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, Spain; REDINREN, Madrid, Spain; School of Medicine, UAM, Madrid, 28040, SpainResearch Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, Spain; REDINREN, Madrid, Spain; School of Medicine, UAM, Madrid, 28040, Spain; IRSIN, Madrid, 28040, Spain; Corresponding author. IIS-Fundacion Jimenez Diaz, Av Reyes Católicos 2, 28040, Madrid, Spain.Research Institute-Fundacion Jimenez Diaz, Autonoma University, Madrid, Spain; REDINREN, Madrid, Spain; Corresponding author. IIS-Fundacion Jimenez Diaz, Av Reyes Católicos 2, 28040 Madrid, Spain.Omeprazole, a proton pump inhibitor used to treat peptic ulcer and gastroesophageal reflux disease, has been associated to chronic kidney disease and acute interstitial nephritis. However, whether omeprazole is toxic to renal cells is unknown. Omeprazole has a lethal effect over some cancer cells, and cell death is a key process in kidney disease. Thus, we evaluated the potential lethal effect of omeprazole over tubular cells.Omeprazole induced dose-dependent cell death in human and murine proximal tubular cell lines and in human primary proximal tubular cell cultures. Increased cell death was observed at the high concentrations used in cancer cell studies and also at lower concentrations similar to those in peptic ulcer patient serum. Cell death induced by omeprazole had features of necrosis such as annexin V/7-AAD staining, LDH release, vacuolization and irregular chromatin condensation. Weak activation of caspase-3 was observed but inhibitors of caspases (zVAD), necroptosis (Necrostatin-1) or ferroptosis (Ferrostatin-1) did not prevent omeprazole-induced death. However, omeprazole promoted a strong oxidative stress response affecting mitochondria and lysosomes and the antioxidant N-acetyl-cysteine reduced oxidative stress and cell death. By contrast, iron overload increased cell death. An adaptive increase in the antiapoptotic protein BclxL failed to protect cells. In mice, parenteral omeprazole increased tubular cell death and the expression of NGAL and HO-1, markers of renal injury and oxidative stress, respectively.In conclusion, omeprazole nephrotoxicity may be related to induction of oxidative stress and renal tubular cell death.http://www.sciencedirect.com/science/article/pii/S2213231719316076NephrotoxicityOmeprazoleOxidative stressCell deathTubular proximal cells |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Miguel Fontecha-Barriuso Diego Martín-Sanchez Julio M. Martinez-Moreno Daniela Cardenas-Villacres Susana Carrasco Maria D. Sanchez-Niño Marta Ruiz-Ortega Alberto Ortiz Ana B. Sanz |
spellingShingle |
Miguel Fontecha-Barriuso Diego Martín-Sanchez Julio M. Martinez-Moreno Daniela Cardenas-Villacres Susana Carrasco Maria D. Sanchez-Niño Marta Ruiz-Ortega Alberto Ortiz Ana B. Sanz Molecular pathways driving omeprazole nephrotoxicity Redox Biology Nephrotoxicity Omeprazole Oxidative stress Cell death Tubular proximal cells |
author_facet |
Miguel Fontecha-Barriuso Diego Martín-Sanchez Julio M. Martinez-Moreno Daniela Cardenas-Villacres Susana Carrasco Maria D. Sanchez-Niño Marta Ruiz-Ortega Alberto Ortiz Ana B. Sanz |
author_sort |
Miguel Fontecha-Barriuso |
title |
Molecular pathways driving omeprazole nephrotoxicity |
title_short |
Molecular pathways driving omeprazole nephrotoxicity |
title_full |
Molecular pathways driving omeprazole nephrotoxicity |
title_fullStr |
Molecular pathways driving omeprazole nephrotoxicity |
title_full_unstemmed |
Molecular pathways driving omeprazole nephrotoxicity |
title_sort |
molecular pathways driving omeprazole nephrotoxicity |
publisher |
Elsevier |
series |
Redox Biology |
issn |
2213-2317 |
publishDate |
2020-05-01 |
description |
Omeprazole, a proton pump inhibitor used to treat peptic ulcer and gastroesophageal reflux disease, has been associated to chronic kidney disease and acute interstitial nephritis. However, whether omeprazole is toxic to renal cells is unknown. Omeprazole has a lethal effect over some cancer cells, and cell death is a key process in kidney disease. Thus, we evaluated the potential lethal effect of omeprazole over tubular cells.Omeprazole induced dose-dependent cell death in human and murine proximal tubular cell lines and in human primary proximal tubular cell cultures. Increased cell death was observed at the high concentrations used in cancer cell studies and also at lower concentrations similar to those in peptic ulcer patient serum. Cell death induced by omeprazole had features of necrosis such as annexin V/7-AAD staining, LDH release, vacuolization and irregular chromatin condensation. Weak activation of caspase-3 was observed but inhibitors of caspases (zVAD), necroptosis (Necrostatin-1) or ferroptosis (Ferrostatin-1) did not prevent omeprazole-induced death. However, omeprazole promoted a strong oxidative stress response affecting mitochondria and lysosomes and the antioxidant N-acetyl-cysteine reduced oxidative stress and cell death. By contrast, iron overload increased cell death. An adaptive increase in the antiapoptotic protein BclxL failed to protect cells. In mice, parenteral omeprazole increased tubular cell death and the expression of NGAL and HO-1, markers of renal injury and oxidative stress, respectively.In conclusion, omeprazole nephrotoxicity may be related to induction of oxidative stress and renal tubular cell death. |
topic |
Nephrotoxicity Omeprazole Oxidative stress Cell death Tubular proximal cells |
url |
http://www.sciencedirect.com/science/article/pii/S2213231719316076 |
work_keys_str_mv |
AT miguelfontechabarriuso molecularpathwaysdrivingomeprazolenephrotoxicity AT diegomartinsanchez molecularpathwaysdrivingomeprazolenephrotoxicity AT juliommartinezmoreno molecularpathwaysdrivingomeprazolenephrotoxicity AT danielacardenasvillacres molecularpathwaysdrivingomeprazolenephrotoxicity AT susanacarrasco molecularpathwaysdrivingomeprazolenephrotoxicity AT mariadsancheznino molecularpathwaysdrivingomeprazolenephrotoxicity AT martaruizortega molecularpathwaysdrivingomeprazolenephrotoxicity AT albertoortiz molecularpathwaysdrivingomeprazolenephrotoxicity AT anabsanz molecularpathwaysdrivingomeprazolenephrotoxicity |
_version_ |
1724605543485538304 |